Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial

For infants with single ventricle malformations undergoing staged repair, interstage mortality is reported at 2% to 20%. The Single Ventricle Reconstruction trial randomized subjects with a single morphologic right ventricle undergoing a Norwood procedure to a modified Blalock–Taussig shunt (MBTS) o...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of thoracic and cardiovascular surgery Vol. 144; no. 4; pp. 896 - 906
Main Authors Ghanayem, Nancy S., Allen, Kerstin R., Tabbutt, Sarah, Atz, Andrew M., Clabby, Martha L., Cooper, David S., Eghtesady, Pirooz, Frommelt, Peter C., Gruber, Peter J., Hill, Kevin D., Kaltman, Jonathan R., Laussen, Peter C., Lewis, Alan B., Lurito, Karen J., Minich, L. LuAnn, Ohye, Richard G., Schonbeck, Julie V., Schwartz, Steven M., Singh, Rakesh K., Goldberg, Caren S.
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.10.2012
Elsevier
Subjects
OR
CPR
SVR
BSA
20
Online AccessGet full text
ISSN0022-5223
1097-685X
1097-685X
DOI10.1016/j.jtcvs.2012.05.020

Cover

More Information
Summary:For infants with single ventricle malformations undergoing staged repair, interstage mortality is reported at 2% to 20%. The Single Ventricle Reconstruction trial randomized subjects with a single morphologic right ventricle undergoing a Norwood procedure to a modified Blalock–Taussig shunt (MBTS) or a right ventricle-to-pulmonary artery shunt (RVPAS). The aim of this analysis was to explore the associations of interstage mortality and shunt type, and demographic, anatomic, and perioperative factors. Participants in the Single Ventricle Reconstruction trial who survived to discharge after the Norwood procedure were included (n = 426). Interstage mortality was defined as death postdischarge after the Norwood procedure and before the stage II procedure. Univariate analysis and multivariable logistic regression were performed adjusting for site. Overall interstage mortality was 50 of 426 (12%)—13 of 225 (6%) for RVPAS and 37 of 201 (18%) for MBTS (odds ratio [OR] for MBTS, 3.4; P < .001). When moderate to severe postoperative atrioventricular valve regurgitation (AVVR) was present, interstage mortality was similar between shunt types. Interstage mortality was independently associated with gestational age less than 37 weeks (OR, 3.9; P = .008), Hispanic ethnicity (OR, 2.6; P = .04), aortic atresia/mitral atresia (OR, 2.3; P = .03), greater number of post-Norwood complications (OR, 1.2; P = .006), census block poverty level (P = .003), and MBTS in subjects with no or mild postoperative AVVR (OR, 9.7; P < .001). Interstage mortality remains high at 12% and is increased with the MBTS compared with the RVPAS if postoperative AVVR is absent or mild. Preterm delivery, anatomic, and socioeconomic factors are also important. Avoiding preterm delivery when possible and close surveillance after Norwood hospitalization for infants with identified risk factors may reduce interstage mortality.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
Kerstin R. Allen's current affiliation is Infinity Pharmaceuticals, Boston, Mass; Sarah Tabbutt's current affiliation is University of California San Francisco, San Francisco, Calif; Peter J. Gruber's current affiliation is Primary Children's Medical Center and University of Utah, Salt Lake City, Utah; David S. Cooper's and Pirooz Egthesady's current affiliation is Cincinnati Children's Medical Center, Cincinnati, Ohio.
ISSN:0022-5223
1097-685X
1097-685X
DOI:10.1016/j.jtcvs.2012.05.020